<ѻýҕl>Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA?ѻýҕl> Local recurrence rate of 1% at 5 years in women ages 50-69 with genomically low-risk disease Dec 08, 2023
<ѻýҕl>EUS-Guided Gastroenterostomy Better Option for Cancer-Related Duodenal Blockagesѻýҕl> However, technique and technology are not widespread Dec 08, 2023
<ѻýҕl>Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancerѻýҕl> Datopotamab deruxtecan was safe and boosted quality of life Dec 08, 2023
<ѻýҕl>Maintenance Pembrolizumab-Olaparib Fails to Boost Survival in TNBCѻýҕl> But better safety profile versus continued pembrolizumab plus chemotherapy Dec 08, 2023
<ѻýҕl>Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDAѻýҕl> Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
<ѻýҕl>Study 'Underscores' Value of Early Fertility Counseling for Breast Cancer Patientsѻýҕl> Younger age, embryo/oocyte cryopreservation at diagnosis tied to an increased chance of pregnancy Dec 08, 2023
<ѻýҕl>More Awareness Needed of Heart Events Tied to Breast Cancer Drugs, Experts Sayѻýҕl> Myriad clinical manifestations of cardiotoxicity must be diagnosed, treated promptly Dec 08, 2023
<ѻýҕl>Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancerѻýҕl> Promising early results with pembrolizumab, nivolumab but event-free survival data still pending Dec 07, 2023
<ѻýҕl>GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patientsѻýҕl> Association strongest in patients with overweight, obesity Dec 07, 2023
<ѻýҕl>Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drugѻýҕl> News, features, and commentary about cancer-related issues Dec 07, 2023
<ѻýҕl>Doing More With Less Bloodѻýҕl> Blood management programs can save money and resources Dec 07, 2023
<ѻýҕl>The Treatment Landscape for Cervical Cancer Has Changedѻýҕl> Our experts discuss the impact of new options and approaches available in the field Dec 07, 2023 video
<ѻýҕl>No Benefit to Adjuvant-Only Immunotherapy in Early TNBCѻýҕl> Neoadjuvant administration of immunotherapy remains the preferred approach Dec 07, 2023
<ѻýҕl>De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemoѻýҕl> Study showed no increase in disease progression when omitting regional nodal irradiation Dec 07, 2023
<ѻýҕl>Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancerѻýҕl> Adding agent to T-DM1 resulted in 2-month progression-free survival improvement Dec 06, 2023
<ѻýҕl>FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuriaѻýҕl> Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
<ѻýҕl>TULSA Effective in Controlling Prostate Cancer Long-Termѻýҕl> At 5 years, median PSA was reduced by 90% Dec 05, 2023
<ѻýҕl>Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCLѻýҕl> Patients with treatment-sensitive disease may benefit most from continued treatment, says expert Dec 05, 2023
<ѻýҕl>After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasmsѻýҕl> Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge Dec 04, 2023
<ѻýҕl>Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDSѻýҕl> 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
<ѻýҕl>'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?ѻýҕl> Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
<ѻýҕl>First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Responseѻýҕl> A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
<ѻýҕl>Non-Covalent BTK Inhibitor Approved for CLLѻýҕl> Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
<ѻýҕl>Charting the Course: From Young Adult Leukemia Patient to Oncologistѻýҕl> My experience shaped how I care for patients today Dec 03, 2023
<ѻýҕl>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dishѻýҕl> News, features, and commentary about cancer-related issues Dec 01, 2023
<ѻýҕl>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancerѻýҕl> Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<ѻýҕl>Year in Review: Follicular Lymphomaѻýҕl> A promising year for bispecific antibodies Dec 01, 2023
<ѻýҕl>Breast Cancer Screening Frequency Makes a Big Survival Differenceѻýҕl> Keeping those mammogram appointments is life-saving, study finds Nov 30, 2023
<ѻýҕl>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancerѻýҕl> Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<ѻýҕl>Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancerѻýҕl> And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
<ѻýҕl>AI Model Can Predict Breast Cancer Risk Regardless of Patient's Raceѻýҕl> Algorithm proved accurate where traditional risk models have failed, but needs more testing Nov 30, 2023
<ѻýҕl>With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokersѻýҕl> Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
<ѻýҕl>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapyѻýҕl> Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<ѻýҕl>Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screeningѻýҕl> The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
<ѻýҕl>FDA Approves First Therapy for Progressive Desmoid Tumorsѻýҕl> Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
<ѻýҕl>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomyѻýҕl> Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<ѻýҕl>Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinomaѻýҕl> Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
<ѻýҕl>Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutationsѻýҕl> Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
<ѻýҕl>Cancer Patient's Final Act: Destroying Medical Debtѻýҕl> Viral campaign will erase some $60 million in medical debt Nov 22, 2023
<ѻýҕl>Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gazaѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 22, 2023